Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025 and Jan 2026.
- Largest single sale: $4.0M (7,193 shares) of Madrigal Pharmaceuticals, Inc. on Dec 10, 2025. Filing
- Last sale before this period: Aug 13, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. (MDGL) | Director | Jul 26, 2016 | Jan 13, 2026 |
| Incyte (INCY) | Former Director | Mar 2, 2004 | May 28, 2020 |
Also a director at
Incyte (INCY) (no filing in the last 18 months)
Recent filings
The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jan 9, 2026, Madrigal Pharmaceuticals, Inc.: sold 24,800 shares for $13.0M, under a disclosed plan; 24,800 shares acquired by exercising options. 2 filings: 1, 2
- Dec 10, 2025, Madrigal Pharmaceuticals, Inc.: sold 24,800 shares for $13.7M, under a disclosed plan; 24,800 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.